Last updated on February 2020

The British Heart Foundation SENIOR-RITA Trial

Brief description of study

SENIOR-RITA is a multicentre prospective open-label trial randomizing patients presenting with type 1 NSTEMI aged 75 years between invasive and conservative treatment strategies, to compare time to cardiovascular death or non-fatal MI within one year from randomization.

Detailed Study Description

The population is getting older and heart artery disease is the biggest killer in the UK. Over recent years, there have been improvements in medications and technologies to treat it, but these have been primarily tested in younger patients. Previous research studies suggest that older patients (75 years and over) are not well represented in clinical research and these patients in particular those that are frail and those with co-morbidities are less likely to receive advanced medications and medical procedures. The current study will enrol patients 75 years and over, presenting with a heart attack. If patients agree to participate, they will be randomly allocated to one of two treatment groups. In the first group, patients will receive the latest medications recommended in heart attack. In the second group, in addition to these medications, patients will have coronary angiography. This will show whether they have any blockages in heart arteries. If appropriate, coronary revascularisation by percutaneous coronary intervention (PCI) commonly known as coronary angioplasty or coronary artery bypass grafting, sometimes called CABG (a surgical procedure in which a blood vessel from the leg, arm or chest is used to bypass a narrowed section of a coronary artery) will be carried out. During the trial, frailty scores, cognition measures, co-morbidity indices, questionnaires on quality of life, NHS and personal social services utilization will be collected from the participant and in addition proxy quality of life information will be collected from the participant's carers. Investigators will evaluate which one of the two treatment groups will do better and live longer. Investigators will also collect information on their quality of life and frailty measures for a 5 year period. The trial hopes to recruit 2300 patients from approximately 30 centres across the UK.

Clinical Study Identifier: NCT03052036

Find a site near you

Start Over

Aberdeen Royal Infirmary

Aberdeen, United Kingdom
  Connect »

Royal Alexandra Hospital

Glasgow, United Kingdom
  Connect »

NHS Ayrshire & Arran

Kilmarnock, United Kingdom
  Connect »

Victoria Hospital, NHS Fife

Kirkcaldy, United Kingdom
  Connect »

Borders General Hospital

Melrose, United Kingdom
  Connect »

South Tees NHS Foundation Trust

Middlesbrough, United Kingdom
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.